Evidence map›Paper›PMID 40502903›Full record

ArticleCureus2025

A Case of Sarcoidosis Diagnosed Based on Progressive Renal Dysfunction and Lymphadenopathy.

Tomohide Sato

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tomohide SatoDivision of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center, Kumamoto, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several series have suggested that kidney involvement (as defined by either histological changes in the kidney or a decline in kidney function in the absence of a biopsy) occurs in approximately 10 to 50 percent of patients with sarcoidosis. A large study examining more than 1200 hospitalized patients with sarcoidosis reported that kidney manifestations were present in approximately 6% of cases. The case is that of an 89-year-old woman. She experienced paroxysmal nocturnal dyspnea starting four days before her visit. Three days before coming to our hospital, she consulted a nearby clinic, leading to a suspicion of heart failure, and she was referred for further evaluation. Physical examination revealed left axillary lymphadenopathy, coarse crackles in both lung fields, and slow pitting edema over both tibial tuberosities. Blood tests showed Cr: 2.10 mg/dL and B-type natriuretic peptide (BNP): 1144.4 pg/mL. The sIL-2R obtained for the purpose of differentiating malignant lymphoma was 3290 U/mL and elevated. A plain chest CT scan showed cardiomegaly, pulmonary edema, pleural effusion, and left axillary lymphadenopathy. Based on subjective symptoms, physical findings, and laboratory test results, the patient was diagnosed with an acute exacerbation of chronic heart failure. Treatment with atrial natriuretic peptide and loop diuretics was started on the same day for heart failure. Her dyspnea gradually improved, and her weight also decreased. Radiographic findings also showed an improvement in pulmonary congestion. However, by the 14th day of hospitalization, her creatinine level had worsened to 5.85 mg/dL, indicating renal dysfunction. Due to persistent lymphadenopathy and rapidly progressing renal dysfunction, renal sarcoidosis was suspected, and the patient was transferred to another hospital for further investigation. A lymph node biopsy from the left inguinal region revealed non-caseating epithelioid cell granulomas. The serum lysozyme level, which has been shown to be elevated in cardiac and renal sarcoidosis, was 30.6 μg/mL. The diagnosis was sarcoidosis, with heart failure and renal failure attributed to cardiac sarcoidosis and granulomatous interstitial nephritis. Maintenance dialysis was decided upon for renal dysfunction. Sarcoidosis is a systemic disease characterized by the appearance of non-caseating epithelioid cell granulomas. Organs such as the heart, kidneys, eyes, lungs, and nervous system, which impact quality of life and prognosis, require careful monitoring over time. Lymphadenopathy, which does not align with the usual course of heart failure, and progressive renal dysfunction despite achieving diuretic effects, should raise suspicion for this condition.

Indexed as

axillary lymphadenopathyheart failure with preserved ejection fractionnon-caseating epithelioid cell granulomarenal failure progressionrenal sarcoidosis

Identifiers

PMID40502903
PMCPMC12152443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.